“…Non‐hematopoietic stem cells encompass the endothelial colony forming cells (ECFCs) or late outgrowth EPCs, which lack CD133 and monocytic markers, such as CD11b, CD14, and CD45, while express Flk‐1/KDR, and CXCR4, CD144, CD105, lectin UEA‐1, vWF, and are positive to AcLDL uptake (Ingram et al, ; Yoder, ). ECFCs could rescue local blood perfusion either indirectly, through the paracrine liberation of growth factors and cytokines, or directly by serving as building blocks for neovessel formation (Collett et al, ; Moccia, Zuccolo, Poletto, et al, ; Richardson & Yoder, ; Sakimoto et al, ; Yoder, ). Similar to CFU‐ECs and CACs, ECFCs may be selected from peripheral blood (PB) and UCB, although the clonogenic potential of UCB‐derived ECFCs (>70 population doublings) is remarkably higher as respect to their peripheral counterparts (20–40 population doublings) (Ingram et al, ).…”